FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
- FDA 近 90 天出现 31 次
- 上一次：同一天稍早 · Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk
发生了什么
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
摘要按规则整理自下方来源原文